광치료 시장 : 광원, 제품, 최종사용자, 용도별 분석 - 시장 규모, 업계 역학, 기회 분석, 예측(2026-2035년)

The global light therapy market is witnessing steady and sustained growth, reflecting its rising prominence as an effective treatment modality across various medical and wellness applications. Valued at USD 1,174.22 million in 2025, the market is projected to expand significantly over the next decade, reaching a valuation of approximately USD 1,942.03 million by 2035. This growth corresponds to a compound annual growth rate (CAGR) of 5.16% during the forecast period from 2026 to 2035, underscoring the increasing acceptance and integration of light therapy technologies worldwide.

Several key factors are driving this upward trajectory. One of the primary growth engines is the rising adoption of non-invasive and drug-free treatment options, which appeal to patients seeking safer and more natural alternatives to conventional pharmaceutical therapies. Light therapy has gained particular traction in managing mental health conditions such as depression and seasonal affective disorder, as well as in treating various skin disorders like acne and psoriasis. Additionally, its utility in pain management is becoming increasingly recognized, offering relief without the risks associated with long-term medication use.

Noteworthy Market Developments

In the light therapy market, Tier 1 companies, such as Signify (Philips), Beurer, and Draeger, stand out as market leaders, leveraging their extensive experience and established reputations to secure lucrative hospital contracts and maintain robust global distribution networks. These firms have built their success on a foundation of innovation and reliability, positioning themselves as trusted providers of light therapy solutions in clinical settings.

On the other hand, Tier 2 companies, including Joovv, Celluma, and PlatinumLED, are characterized as disruptors in the industry, primarily targeting the "prosumer" and home-use markets. These digital-native brands have adopted innovative marketing strategies, using influencer marketing and direct sales approaches to reach consumers directly, effectively bypassing traditional medical distribution channels. By leveraging social media platforms and online communities, these companies have successfully cultivated a loyal customer base that values the convenience and accessibility of light therapy products for personal use.

The competitive dynamics between these tiers highlight the evolving landscape of the light therapy market. While Tier 1 companies continue to dominate institutional sales and maintain strong relationships with healthcare providers, Tier 2 disruptors are redefining consumer engagement and access to light therapy solutions. This duality in the market not only fosters innovation but also encourages a broader range of product offerings, catering to both professional and home-use applications.

Core Growth Drivers

The ongoing mental health crisis, particularly exacerbated by the events following 2020, is a significant factor propelling growth in the light therapy market, especially in relation to non-pharmacological interventions. The surge in cases of Major Depressive Disorder (MDD) and Seasonal Affective Disorder (SAD) has resulted in a notable imbalance between the demand for psychiatric care and the available supply of mental health services. This crisis has prompted both patients and healthcare providers to seek alternative treatment options that do not rely solely on traditional pharmacological approaches.

Emerging Opportunity Trends

The future of light therapy is poised to be transformed by the emergence of OLED patches, a cutting-edge technology that promises to redefine how photobiomodulation (PBM) is delivered. Unlike traditional treatments that require patients to sit in front of bulky panels for fixed periods, OLED patches offer a flexible, wearable solution that adheres directly to the skin. These patches are designed to deliver low-dose, continuous light therapy throughout the day, allowing for a more seamless integration of treatment into patients' daily lives. This innovation has the potential to greatly enhance the convenience and accessibility of light therapy, making it easier for users to maintain consistent treatment regimens.

Barriers to Optimization

A growing concern threatening the light therapy market is the rapid proliferation of high-powered, unshielded LED devices, which pose significant safety risks to consumers. These devices, particularly those emitting high-irradiance blue light at around 415nm and near-infrared (NIR) light, have been linked to potential retinal photochemical injury when users are exposed directly to the eyes. Such risks are increasingly coming under scrutiny as more consumers adopt these powerful devices without proper guidance or protective measures, leading to heightened awareness about the dangers of improper use.

Detailed Market Segmentation

By Product, the handheld devices segment captured the largest market share within the light therapy market, reflecting a significant shift in how consumers access and engage with dermatological treatments. This growth is largely driven by the aggressive "consumerization" of clinical dermatology, which has made advanced skincare technologies more accessible and user-friendly for everyday consumers. Unlike bulky full-body panels or stationary light therapy stands that require dedicated space and longer treatment times, handheld devices-such as wands, combs, and spot-treatment units-offer portability, convenience, and targeted application.

By Application, the sleep disorder segment garnered substantial revenue within the light therapy market, reflecting a significant shift in consumer health priorities and medical understanding. This growth has been fundamentally driven by the global post-pandemic surge in insomnia cases, which highlighted the widespread impact of disrupted sleep patterns on mental and physical well-being. The pandemic's effects on daily routines, stress levels, and social interactions have contributed to a rise in sleep-related issues, prompting increased demand for effective, non-pharmaceutical treatments such as light therapy.

By End-Use, by 2026, the Home Healthcare segment has solidified its leading position in the light therapy market, marking a significant structural shift in how photomedicine is delivered and accessed. This transformation reflects a broader trend toward decentralizing healthcare from clinical settings to patients' homes, allowing individuals to take a more active role in managing their health and wellness. The convenience and accessibility of home-based light therapy devices have greatly expanded the market, making effective treatments available to a wider audience without the need for frequent clinical visits.

By Light Type, in the rapidly maturing light therapy market of 2026, the Red Light spectrum, which ranges from 600nm to 700nm, has firmly established itself as the leading segment in terms of revenue generation. This specific wavelength range has gained widespread recognition for its therapeutic benefits, driving strong demand across various medical and wellness applications. As a result, it now accounts for over 36% of the total market share, making it the most significant contributor to the industry's growth.

Segment Breakdown

By Product

• Light Box
• Floor and Desk Lamps
• Handheld Devices
• Light Visor
• Dawn Simulator
• Light Therapy Lamps

By Application

• Psoriasis
• Vitiligo
• Eczema
• Acne Vulgaris
• SAD/Winter Blues
• Sleeping Disorders

By Light Type

• Blue Light
• Red Light
• White Light

By End User

• Dermatology Clinics
• Home Healthcare

By Region

• North America
• The U.S.
• Canada
• Mexico
• Europe
• Western Europe
• The UK
• Germany
• France
• Italy
• Spain
• Rest of Western Europe
• Eastern Europe
• Poland
• Russia
• Rest of Eastern Europe
• Asia Pacific
• China
• India
• Japan
• Australia & New Zealand
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East & Africa (MEA)
• Saudi Arabia
• South Africa
• UAE
• Rest of MEA
• South America
• Argentina
• Brazil
• Rest of South America

Geography Breakdown

• North America holds a commanding 38% share of the global light therapy market, reflecting the region's advanced healthcare infrastructure and strong focus on innovation. This significant market presence is partly driven by the relatively high prevalence of psoriasis, affecting approximately 3% of the population, which has spurred demand for effective treatment options. The region's healthcare providers and consumers have rapidly embraced FDA-cleared LED-based phototherapy devices, which offer safe and efficient treatment alternatives.
• In the United States, companies are at the forefront of developing AI-driven personalization features that enhance treatment efficacy and user experience. For example, VitalLight has pioneered app-controlled dosing systems, allowing patients to customize their phototherapy regimens with greater precision and convenience. Additionally, the U.S. market is witnessing the rise of combination therapies that merge traditional phototherapy with biologic drugs, providing improved outcomes for patients with chronic skin conditions.
• The robust investment landscape further fuels growth in the region. In 2025 alone, venture capital firms invested approximately $280 million in photomedtech startups, signaling strong confidence in the sector's potential. This influx of funding supports research, product development, and market expansion, driving continuous improvements in light therapy technology. Beyond the United States, Canada contributes to the market by focusing on niche applications such as treating seasonal affective disorder (SAD) and eczema, particularly among the geriatric population. These specialized uses highlight the versatility of light therapy across different demographic groups and medical needs.

Leading Market Participants

• Beurer
• BioPhotas
• Daylight Company
• Koninklijke Philips
• Lumie
• Naturebright
• Northern Light Technologies
• Verilux
• Zepter International
• Zerigo Health
• Other Prominent Players

Table of Content

Chapter 1. Executive Summary: Global Light Therapy Market

Chapter 2. Report Description

• 2.1. Research Framework
  • 2.1.1. Research Objective
  • 2.1.2. Market Definitions
  • 2.1.3. Market Segmentation
• 2.2. Research Methodology
  • 2.2.1. Market Size Estimation
  • 2.2.2. Qualitative Research
    • 2.2.2.1. Primary & Secondary Sources
  • 2.2.3. Quantitative Research
    • 2.2.3.1. Primary & Secondary Sources
  • 2.2.4. Breakdown of Primary Research Respondents, By Region
  • 2.2.5. Data Triangulation
  • 2.2.6. Assumption for Study

Chapter 3. Global Light Therapy Market Overview

• 3.1. Industry Value Chain Analysis
  • 3.1.1. Raw Material Suppliers
  • 3.1.2. LED Module & Device Manufacturers
  • 3.1.3. Medical & Wellness Device Assemblers
  • 3.1.4. Distribution Channel
  • 3.1.5. End User
• 3.2. Industry Outlook
  • 3.2.1. Rising demand for skin rejuvenation
  • 3.2.2. Expansion of home-use light therapy devices
  • 3.2.3. Increasing adoption in pain & inflammation therapy
• 3.3. PESTLE Analysis
• 3.4. Porter's Five Forces Analysis
  • 3.4.1. Bargaining Power of Suppliers
  • 3.4.2. Bargaining Power of Buyers
  • 3.4.3. Threat of Substitutes
  • 3.4.4. Threat of New Entrants
  • 3.4.5. Degree of Competition
• 3.5. Market Growth and Outlook
  • 3.5.1. Market Revenue Estimates and Forecast (US$ Mn), 2020-2035
• 3.6. Market Attractiveness Analysis
  • 3.6.1. By Product Type
• 3.7. Actionable Insights (Analyst's Recommendations)

Chapter 4. Competition Dashboard

• 4.1. Market Concentration Rate
• 4.2. Company Market Share Analysis (Value %), 2025
• 4.3. Competitor Mapping & Benchmarking

Chapter 5. Global Light Therapy Market Analysis

• 5.1. Market Dynamics and Trends
  • 5.1.1. Growth Drivers
    • 5.1.1.1. Growing demand for non-invasive, drug-free treatment solutions is being driven
  • 5.1.2. Restraints
  • 5.1.3. Opportunity
  • 5.1.4. Key Trends
• 5.2. Market Size and Forecast, 2020-2035 (US$ Mn)
  • 5.2.1. By Product
    • 5.2.1.1. Key Insights
      • 5.2.1.1.1. Light Box
      • 5.2.1.1.2. Floor and Desk Lamps
      • 5.2.1.1.3. Handheld Devices
      • 5.2.1.1.4. Light Visor
      • 5.2.1.1.5. Dawn Simulator
      • 5.2.1.1.6. Light Therapy Lamps
  • 5.2.2. By Application
    • 5.2.2.1. Key Insights
      • 5.2.2.1.1. Psoriasis
      • 5.2.2.1.2. Vitiligo
      • 5.2.2.1.3. Eczema
      • 5.2.2.1.4. Acne Vulgaris
      • 5.2.2.1.5. SAD/Winter Blues
      • 5.2.2.1.6. Sleeping Disorders
  • 5.2.3. By Light Type
    • 5.2.3.1. Key Insights
      • 5.2.3.1.1. Blue Light
      • 5.2.3.1.2. Red Light
      • 5.2.3.1.3. White Light
  • 5.2.4. By End User
    • 5.2.4.1. Key Insights
      • 5.2.4.1.1. Dermatology Clinics
      • 5.2.4.1.2. Home Healthcare
  • 5.2.5. By Region
    • 5.2.5.1. Key Insights
      • 5.2.5.1.1. North America
        • 5.2.5.1.1.1. The U.S.
        • 5.2.5.1.1.2. Canada
        • 5.2.5.1.1.3. Mexico
      • 5.2.5.1.2. Europe
        • 5.2.5.1.2.1. Western Europe
          • 5.2.5.1.2.1.1. The UK
          • 5.2.5.1.2.1.2. Germany
          • 5.2.5.1.2.1.3. France
          • 5.2.5.1.2.1.4. Italy
          • 5.2.5.1.2.1.5. Spain
          • 5.2.5.1.2.1.6. Rest of Western Europe
        • 5.2.5.1.2.2. Eastern Europe
          • 5.2.5.1.2.2.1. Poland
          • 5.2.5.1.2.2.2. Russia
          • 5.2.5.1.2.2.3. Rest of Eastern Europe
      • 5.2.5.1.3. Asia Pacific
        • 5.2.5.1.3.1. China
        • 5.2.5.1.3.2. India
        • 5.2.5.1.3.3. Japan
        • 5.2.5.1.3.4. South Korea
        • 5.2.5.1.3.5. Australia & New Zealand
        • 5.2.5.1.3.6. ASEAN
        • 5.2.5.1.3.7. Rest of Asia Pacific
      • 5.2.5.1.4. Middle East & Africa
        • 5.2.5.1.4.1. UAE
        • 5.2.5.1.4.2. Saudi Arabia
        • 5.2.5.1.4.3. South Africa
        • 5.2.5.1.4.4. Rest of MEA
      • 5.2.5.1.5. South America
        • 5.2.5.1.5.1. Argentina
        • 5.2.5.1.5.2. Brazil
        • 5.2.5.1.5.3. Rest of South America

Chapter 6. North America Light Therapy Market Analysis

• 6.1. Market Dynamics and Trends
  • 6.1.1. Growth Drivers
  • 6.1.2. Restraints
  • 6.1.3. Opportunity
  • 6.1.4. Key Trends
• 6.2. Market Size and Forecast, 2020-2035 (US$ Mn)
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By Light Type
  • 6.2.4. By End-User
  • 6.2.5. By Country

Chapter 7. Europe Light Therapy Market Analysis

• 7.1. Market Dynamics and Trends
  • 7.1.1. Growth Drivers
  • 7.1.2. Restraints
  • 7.1.3. Opportunity
  • 7.1.4. Key Trends
• 7.2. Market Size and Forecast, 2020-2035 (US$ Mn)
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By Light Type
  • 7.2.4. By End-User
  • 7.2.5. By Country

Chapter 8. Asia Pacific Light Therapy Market Analysis

• 8.1. Market Dynamics and Trends
  • 8.1.1. Growth Drivers
  • 8.1.2. Restraints
  • 8.1.3. Opportunity
  • 8.1.4. Key Trends
• 8.2. Market Size and Forecast, 2020-2035 (US$ Mn)
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By Light Type
  • 8.2.4. By End-User
  • 8.2.5. By Country

Chapter 9. Middle East & Africa Light Therapy Market Analysis

• 9.1. Market Dynamics and Trends
  • 9.1.1. Growth Drivers
  • 9.1.2. Restraints
  • 9.1.3. Opportunity
  • 9.1.4. Key Trends
• 9.2. Market Size and Forecast, 2020-2035 (US$ Mn)
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By Light Type
  • 9.2.4. By End-User
  • 9.2.5. By Country

Chapter 10. South America Light Therapy Market Analysis

• 10.1. Market Dynamics and Trends
  • 10.1.1. Growth Drivers
  • 10.1.2. Restraints
  • 10.1.3. Opportunity
  • 10.1.4. Key Trends
• 10.2. Market Size and Forecast, 2020-2035 (US$ Mn)
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By Light Type
  • 10.2.4. By End-User
  • 10.2.5. By Country

Chapter 11. Company Profile (Company Overview, Company Timeline, Organization Structure, Key Product landscape, Financial Matrix, Key Customers/Sectors, Key Competitors, SWOT Analysis, Contact Address, and Business Strategy Outlook)

• 11.1. Global Players
  • 11.1.1. Beurer
  • 11.1.2. BioPhotas
  • 11.1.3. Daylight Company
  • 11.1.4. Koninklijke Philips
  • 11.1.5. Lumie
  • 11.1.6. Naturebright
  • 11.1.7. Northern Light Technologies
  • 11.1.8. Verilux
  • 11.1.9. Zepter International
  • 11.1.10. Zerigo Health
  • 11.1.11. Other Prominent Players

Chapter 12. Annexure

• 13.1 List of Secondary Sources
• 13.2 Key Country Markets- Macro Economic Outlook/Indicators